Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
Compose a Response to This Article
Other responses
No responses have been published for this article.
